BAM's 36% Profit Jump Signals Better Margins-Now the Question Is Whether 6.5% Sticks

BAM's half-year improvement shifted the debate from recovery to durability

BAM's half-year results changed the conversation. After a 36% EBITDA rise to €240 million and a 6.9% half-year margin, the market is no longer asking whether BAM can catch a tailwind. It is asking whether this level of profitability can hold. That is a better problem to have, but it is also a tougher test.

A few years ago, BAM could lean on a familiar rebuild narrative: steady demand, slow recovery, and modest upside. Now the story is different. Investors are paying attention because BAM has raised its full-year 2026 adjusted EBITDA margin guidance to at least 6.5%. That moves the stock from a recovery story to an execution story. If management can retain more cash from each euro of sales, the market may value BAM less like a tired contractor and more like a business with structurally better margins.

The latest quarter added both hope and friction. BAM posted Q2 EPS of $0.57 versus $0.52 consensus, but revenue was $4.00 billion versus $4.06 billion expected. Bulls see margin discipline beating through a slight revenue miss. Skeptics see a warning that growth may be softening just as expectations rise.

The core durability question is whether BAM's best half was a spike or a new base. The supporting data is constructive: half-year revenue of €3.5 billion, net profit of €127 million, and an order book of €12.6 billion. That gives management time to prove the point. Over the next few quarters, though, the key watchpoint is simple: if margins slip back while revenue stays flat, the rerating story weakens quickly.

Netherlands execution and UK & Ireland claim help explain the margin improvement

This half was not just about more revenue. It was also about a better mix of work across divisions.

The Netherlands remains the clearest proof point

The Netherlands produced the strongest profit mix in the group: Netherlands revenue of €1.68 billion generated EBITDA of €138 million, for an 8.2% margin. That matters because the improvement looked broad-based rather than dependent on a single non-recurring item. Management attributed the result to strong operational execution, a 35% increase in home sales to 935 units, and a higher contribution from civil engineering and energy transition projects.

The Dutch order book also rose 7% to €6.0 billion, which gives BAM visibility into keeping that mix going. If the Netherlands can stay near that profitability level, it does a lot of the heavy lifting for the full-year margin target.

UK & Ireland improved, but the margin mix is less clean than the Dutch case

UK & Ireland added support, but with more caveats. Revenue rose to €1.72 billion and EBITDA reached €98 million, giving a 5.7% margin. That improvement was helped by profitability gains in UK construction and positive claim settlements, but it was partly offset by additional costs related to the handover of the National Children's Hospital in Ireland.

The careful read, then, is cautiously positive. The segment clearly improved, but because claim settlements helped and one Ireland project created friction, investors should not treat that margin level as fully run-rate yet.

A stronger balance sheet makes the margin story more credible

Margin improvement matters more when the company has balance-sheet room to be selective. BAM finished the half with cash and cash equivalents at €715 million, a cash range of €715–750 million, and solvency of 22.9%. It also generated operating cash flow of €211 million. That should give the business more flexibility to turn down weaker work instead of taking projects just to keep capacity filled.

There are still normal operating trade-offs. Trade working capital efficiency was -12.5%, a touch worse than last year's -11.9%, which is a reminder that better reported margins can still be eroded if cash gets tied up on projects. The effective tax rate also rose to 18% from 10% in H1, which tempers the headline net-profit increase, though it does not change the main operating point: BAM kept more cash in the register from each euro of sales.

The next test is whether BAM can defend at least 6.5% adjusted EBITDA margin

BAM has moved from showing that margins can improve to defending a full-year adjusted EBITDA margin expected at least 6.5% against a backdrop of a €12.6 billion order book. That is a better position to be in, but also a harsher one. With the Dutch order book up 7% to €6 billion and the UK & Ireland order book at €6.1 billion, investors no longer need to assume demand weakness is doing the heavy lifting. The real question is whether the work in the pipeline has the right mix and pricing discipline to sustain those margins.

Why the bull case is credible

The bullish case does not require another explosive growth sprint. It requires better tendering discipline, better mix, and less pressure to accept lower-quality work. Management has tied its outlook to disciplined contract selection and risk management, and that matters because a higher margin target is easier to defend when it comes from selecting the right part of the business rather than simply working harder.

The Netherlands remains the cleanest proof point. If that market keeps producing better-margin work, BAM does not need every segment to be perfect for 6.5% to hold.

Why skeptics still have a case

The bearish case does not depend on the half-year results being weak. It rests on a simpler idea: a large order book can still contain lower-margin projects, and one quarter helped by claim settlements in UK & Ireland may not repeat. The Ireland project handover costs are another reminder that execution risk does not disappear just because the group results look better.

Backlog gives visibility, but visibility is not the same as guaranteeing profit. The next few quarters need to show that higher margins are coming from contract quality and execution, not from a favorable one-off mix.

What matters most in the next few quarters

For now, BAM looks more like a margin-watch story than a blind backlog story. The key signals are:

• whether the Netherlands margin profile holds
• whether UK & Ireland can improve without relying as heavily on claim settlements
• whether cash conversion stays healthy despite the slight working-capital slowdown
• whether management can convert part of the €12.6 billion order book into realized margin, not just more revenue